Cargando…

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing

While sensitivity and specificity are important characteristics for any diagnostic test, the influence of prevalence is equally, if not more, important when such tests are used in community screening. We review the concepts of positive/negative predictive values (PPV/NPV) and how disease prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Chin-Shern, Aw, Tar-Choon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698426/ https://www.ncbi.nlm.nih.gov/pubmed/34940002 http://dx.doi.org/10.3390/antib10040050

Ejemplares similares

SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?
por: Lau, Chin Shern, et al.
Publicado: (2022)

Considerations in Understanding Vaccine Effectiveness
por: Lau, Chin Shern, et al.
Publicado: (2022)

Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region
por: Lau, Chin Shern, et al.
Publicado: (2022)

SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore
por: Lau, Chin Shern, et al.
Publicado: (2022)

Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Lau, Chin-Shern, et al.
Publicado: (2021)

Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
por: Lau, Chin Shern, et al.
Publicado: (2022)

Too hard to die: Exercise training mediates specific and immediate SARS-CoV-2 protection
por: Papadopoulos, Konstantinos I, et al.
Publicado: (2022)

The Clinical Significance and Utility of Routine Screening for Macroprolactin in Patients With Hyperprolactinemia
por: Zeng, Wanling, et al.
Publicado: (2021)

Commentary: SARS-CoV-2 in tears: It really matters
por: Biswas, Jyotirmay, et al.
Publicado: (2021)

Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism
por: Papadopoulos, Konstantinos, et al.
Publicado: (2023)

210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine
por: Lau, Chin Shern, et al.
Publicado: (2022)

The challenge of asymptomatic SARS-CoV-2 transmission in care homes
por: Belmin, Joël, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

My Experience with SARS-CoV-2, with a Focus on Testing
por: Cotter, Peggy A.
Publicado: (2020)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies
por: Chong, Pek Yoon, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

Corrigendum: Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies
por: Chong, Pek Yoon, et al.
Publicado: (2022)

RT-qPCR Testing of SARS-CoV-2: A Primer
por: Bustin, Stephen A., et al.
Publicado: (2020)

Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)

Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
por: Finsterer, Josef, et al.
Publicado: (2020)

Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests
por: Eyal, Nir, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge
por: Antinori, Spinello, et al.
Publicado: (2020)

The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
por: Greninger, Alexander L., et al.
Publicado: (2020)

SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America
por: La Marca, Antonio, et al.
Publicado: (2020)

Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing
por: Cicuttin, Enrico, et al.
Publicado: (2020)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

SARS-CoV-2 Invasion and Pathological Links to Prion Disease
por: Lukiw, Walter J., et al.
Publicado: (2022)

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome in children is challenging like in adults
por: Finsterer, Josef
Publicado: (2022)

Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
por: Rahman, Smaranika, et al.
Publicado: (2022)

Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing
por: Locher, Kerstin, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study
por: Comar, Manola, et al.
Publicado: (2021)

Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges
por: Quadir, Neha, et al.
Publicado: (2022)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjvaruoch6pn0hhlgt7ch0og1j